The current landscape of m6A modification in urological cancers

被引：1
|
作者：
Zeng, Yaohui [1 ]
Lv, Cai [1 ]
Wan, Bangbei [1 ]
Gong, Binghao [1 ]
机构：
[1] Cent South Univ, Dept Urol, Xiangya Sch Med, Affiliated Haikou Hosp, Haikou, Peoples R China
来源：
PEERJ | 2023年 / 11卷
关键词：
N6-methyladenosine; Renal cell carcinoma; Bladder cancer; Prostate cancer; Epigenetic modifications; Urological cancer; RNA METHYLATION REGULATORS; METHYLTRANSFERASE METTL3 PROMOTES; MESSENGER-RNA; GENE-EXPRESSION; BLADDER-CANCER; PROGRESSION; FTO; TRANSLATION; METASTASIS; CARCINOMA;
D O I：
10.7717/peerj.16023
中图分类号：
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号：
07 ; 0710 ; 09 ;
摘要：
N6-methyladenosine (m6A) methylation is a dynamic and reversible procession of epigenetic modifications. It is increasingly recognized that m6A modification has been involved in the tumorigenesis, development, and progression of urological tumors. Emerging research explored the role of m6A modification in urological cancer. In this review, we will summarize the relationship between m6A modification, renal cell carcinoma, bladder cancer, and prostate cancer, and discover the biological function of m6A regulators in tumor cells. We will also discuss the possible mechanism and future application value used as a potential biomarker or therapeutic target to benefit patients with urological cancers.
引用
收藏
页数：24
相关论文
共 50 条
  • [21] The regulatory mechanism of m6A modification in gastric cancer
    Wu, Si
    Li, Chunming
    Zhou, Hanghao
    Yang, Ying
    Liang, Na
    Fu, Yue
    Luo, Qingqing
    Zhan, Yali
    DISCOVER ONCOLOGY, 2024, 15 (01)
  • [22] Dynamic regulation and functions of mRNA m6A modification
    Wang, Shanshan
    Lv, Wei
    Li, Tao
    Zhang, Shubing
    Wang, Huihui
    Li, Xuemei
    Wang, Lianzi
    Ma, Dongyue
    Zang, Yan
    Shen, Jilong
    Xu, Yuanhong
    Wei, Wei
    CANCER CELL INTERNATIONAL, 2022, 22 (01)
  • [23] Crosstalk between m6A modification and autophagy in cancer
    Chen, Tao
    Zheng, Liying
    Luo, Peiyue
    Zou, Jun
    Li, Wei
    Chen, Qi
    Zou, Junrong
    Qian, Biao
    CELL AND BIOSCIENCE, 2024, 14 (01)
  • [24] Importance of m N6-methyladenosine (m6A) RNA modification in cancer
    Tuncel, Gulten
    Kalkan, Rasime
    MEDICAL ONCOLOGY, 2019, 36 (04)
  • [25] The FTO m6A demethylase inhibits the invasion and migration of prostate cancer cells by regulating total m6A levels
    Zhu, Kai
    Li, Ying
    Xu, Yikai
    LIFE SCIENCES, 2021, 271
  • [26] Overview of m6A and circRNAs in human cancers
    Zhang, Leyu
    Wang, Xi
    Zhao, Wei
    Liu, Jingwen
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (09) : 6769 - 6784
  • [27] Prognostic and clinicopathological value of m6A regulators in human cancers: a meta-analysis
    Su, Zhangci
    Xu, Leyao
    Dai, Xinning
    Zhu, Mengyao
    Chen, Xiaodan
    Li, Yuanyuan
    Li, Jie
    Ge, Ruihan
    Cheng, Bin
    Wang, Yun
    AGING-US, 2022, 14 (21): : 8818 - 8838
  • [28] The m6A Methyltransferase METTL3 Is Functionally Implicated in DLBCL Development by Regulating m6A Modification in PEDF
    Cheng, Yingying
    Fu, Yuanyuan
    Wang, Ying
    Wang, Jinbi
    FRONTIERS IN GENETICS, 2020, 11
  • [29] The Role of RNA m6A Modification in Cancer Glycolytic Reprogramming
    Li, Yuanqi
    Huang, Hao
    Wu, Shaoxian
    Zhou, You
    Huang, Tao
    Jiang, Jingting
    CURRENT GENE THERAPY, 2023, 23 (01) : 51 - 59
  • [30] Reshaping the role of m6A modification in cancer transcriptome: a review
    Yang, Guanqun
    Sun, Zhigang
    Zhang, Nan
    CANCER CELL INTERNATIONAL, 2020, 20 (01)
12345